Medical Developments International (ASX: MVP) – medical products distributor
ABOUT COMPANY
Medical Developments International (MVP) (https://www.medicaldev.com/) distributes an industry-leading range of products in the areas of pain management (Penthrox), asthma, and resuscitation globally.
CAPITAL STRUCTURE
| ASX Code | Share Price | Shares | Option (In) | Market Cap | Cash/Asset ($m) |
| MVP | 0.585 | 86305219 | 50488553.1150 | 19.4/34.9 |
| Holders No | Top 20 (Cur) | Top 20 (Pre) | Director Hold | Performance Right | Note |
| 11527 | 43.8% | 48.82% | 1.22% | 2074121 |
BUSINESS
Below is the company’s past five years performance
| MVP | 2023 | 2022 | 2021 | 2020 | 2019 |
| Operation Revenue | 32337 | 21943 | 16329 | ||
| Cost of Sale | -13950 | -9331 | -6074 | ||
| Gross Revenue | 18387 | 12612 | 10255 | 0 | 0 |
| Gross Margin | 0.5686 | 0.5748 | 0.6280 | 0 | 0 |
| Overheads | -35547 | -25362 | -21421 | ||
| Fixed Overheads | |||||
| Variable Overheads | |||||
| Total Operation Expense | -35547 | -25362 | -21421 | 0 | 0 |
| Operation Profit | -17160 | -12750 | -11166 | 0 | 0 |
| Other Revenue | 12144 | -542 | -13 | ||
| Interest Expense | 562 | 368 | -50 | ||
| D&A | -3113 | -2945 | -3749 | ||
| Income Tax | 1883 | 3501 | 2413 | ||
| Net Profit | -5684 | -12368 | -12565 | 0 | 0 |
| NOTES |
The company lost the Chinese market in 2022 but intends to penetrate the US market in the future. The company started to search US partners in April 2023.
The company will need $40m in revenue to break even.
SUMMARY
The company makes a poor corporate effort, its website is not even shown up on google when searching for the company name.